Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Non-Current Debt (2020 - 2025)

Pulmonx (LUNG) has disclosed Non-Current Debt for 6 consecutive years, with $37.0 million as the latest value for Q3 2025.

  • Quarterly Non-Current Debt changed 0.3% to $37.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $37.0 million through Sep 2025, changed 0.3% year-over-year, with the annual reading at $34.0 million for FY2024, 3.1% down from the prior year.
  • Non-Current Debt for Q3 2025 was $37.0 million at Pulmonx, roughly flat from $37.0 million in the prior quarter.
  • The five-year high for Non-Current Debt was $37.2 million in Q1 2023, with the low at $179000.0 in Q4 2021.
  • Average Non-Current Debt over 5 years is $23.8 million, with a median of $32.0 million recorded in 2024.
  • The sharpest move saw Non-Current Debt crashed 68.26% in 2021, then surged 9527.93% in 2022.
  • Over 5 years, Non-Current Debt stood at $179000.0 in 2021, then soared by 9527.93% to $17.2 million in 2022, then skyrocketed by 103.6% to $35.1 million in 2023, then decreased by 3.1% to $34.0 million in 2024, then grew by 8.89% to $37.0 million in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $37.0 million, $37.0 million, and $29.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.